Collegium Pharmaceutical Analyst Ratings
Jefferies Upgrades Collegium to Buy, Cites Upside Related to LOEs
Cardiol Therapeutics Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Aquestive Therapeutics, Maintains $9 Price Target
Aquestive Therapeutics Analyst Ratings
Alkermes Analyst Ratings
HC Wainwright & Co. Reiterates Neutral on Alkermes, Maintains $35 Price Target
Harrow Analyst Ratings
Lake Street Maintains Buy on Harrow, Raises Price Target to $25
Analysts Conflicted on These Healthcare Names: Cooper Co (COO), Canopy Growth (CGC) and BioMarin Pharmaceutical (BMRN)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Veeva Systems (VEEV), Intra-Cellular Therapies (ITCI) and Phreesia (PHR)
Analysts Offer Insights on Healthcare Companies: Springworks Therapeutics (SWTX), Cyclo Therapeutics (CYTH) and Oncternal Therapeutics (ONCT)
Cyclo Therapeutics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Cyclo Therapeutics, Maintains $3 Price Target
Analysts Conflicted on These Healthcare Names: Canopy Growth (CGC), Ultragenyx Pharmaceutical (RARE) and Roivant Sciences (ROIV)
Teva Pharmaceutical Indus Analyst Ratings
Buy Rating Justified for Petros Pharmaceuticals Amid AI Integration and Strategic OTC Expansion
Analysts Are Bullish on These Healthcare Stocks: Assertio Therapeutics (ASRT), SurModics (SRDX)
Neurocrine Biosciences Analyst Ratings